Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Heart Rate Variability in White Coat Hypertension and Essential Hypertension

This study has been completed.
Information provided by:
Regional Hospital Holstebro Identifier:
First received: February 3, 2006
Last updated: September 8, 2006
Last verified: September 2006
The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.

Condition Intervention
Essential Hypertension
White Coat Hypertension
Procedure: Monitoring of heart rate variability

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Further study details as provided by Regional Hospital Holstebro:

Estimated Enrollment: 65

Ages Eligible for Study:   30 Years to 70 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • age 30-70 years
  • office BP >150/95 mmHg and 24-h ambulatory BP =/>135/85 mmHg
  • office BP >150/95 mmHg and 24-h ambulatory BP <135/85 mmHg
  • office BP <150/95 mmHg and 24-h ambulatory BP <135/85 mmHg

Exclusion Criteria:

  • Clinical signs of disease of the heart, lungs, liver, kidneys, brain or endocrine organs
  • neoplastic disease
  • daily use of medicine
  • alcohol abuse
  • abnormal laboratory screening including blood-hemoglobin, blood-white cell count, plasma-creatinine, plasma-alanine-amino-transaminases, plasma-albumin, plasma-sodium, plasma-potassium, urinary glucose, urinary albumin; electrocardiogram
  • pregnancy
  • unwillingness to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00286884

Department of Medical Research, Holstebro Hospital
Holstebro, Denmark, 7500
Sponsors and Collaborators
Regional Hospital Holstebro
Principal Investigator: Line B Madsen, MD Regional Hospital Holstebro
Study Chair: Erling B Pedersen, MD Regional Hospital Holstebro
  More Information Identifier: NCT00286884     History of Changes
Other Study ID Numbers: MED.RES.HOS.2003.01.LBM 
Study First Received: February 3, 2006
Last Updated: September 8, 2006
Health Authority: Denmark: Ethics Committee

Additional relevant MeSH terms:
White Coat Hypertension
Vascular Diseases
Cardiovascular Diseases processed this record on October 21, 2016